JUN and central nervous system cancer: FOSL1 and JUN are the downstream factors in the PI3K/Akt pathway, and they can form a stable heterodimer known as AP-1, a transcriptional activator that can influence glioma behavior, reflected by elevated levels of phenotype markers BCL2 and PCNA.